Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.00    -0.50 (-0.73%)
Bid:
67.00
Ask:
69.00
Spread: 2.00 (2.985%)
Market Cap: £59.89m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Calnex and Viavi Partnership

6 Nov 2025 11:30

RNS Number : 3642G
Calnex Solutions PLC
06 November 2025
 

RNS Reach

06 November 2025

Calnex Solutions plc

("Calnex" or the "Company")

Calnex and Viavi Partnership

Simplifying Open RAN Conformance and Performance with Comprehensive Pre-Certification Testbeds

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets, has partnered with VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) to provide a suite of test solutions for the comprehensive testing of Open RAN products across the protocol, signal and timing domains. These testbeds simplify and reduce the cost of developing an in-house Open RAN testing for pre-certification validation and can be set up immediately with no debugging.

The shift to Open RAN and AI-RAN in 5G and 6G systems is opening the telecom infrastructure market to a greater number of companies, including startups and university spinouts. While this has the potential to accelerate innovation, multivendor ecosystems require strict adherence to performance, security, interoperability and reliability standards. Although final O-RAN ALLIANCE and 3GPP certification takes place at official labs, pre-testing is essential to ensure success and avoid the costs of failing.

Through the Calnex and VIAVI partnership, manufacturers of O-RU, O-DU and O-CU equipment can access three testbeds immediately. The integrated systems from Calnex and VIAVI allow for full O-RAN and 3GPP conformance testing, while also emulating realistic network impairments like jitter and delay. This enables the rigorous testing of key functions.

For further information on the partnership, please visit: News - Calnex

Tommy Cook, Chief Executive Officer and founder of Calnex, said: "O-RAN has opened up traditional telecoms architecture to new market entrants, creating a widening pool of organisations requiring telecoms test solutions. We have experienced success with our product offerings in recent years as a result of the O-RAN initiative, and with this partnership with VIAVI, a global leader in communications test and measurement technologies, we hope to build on that yet further.

"Companies urgently need in-house labs to validate their Open RAN systems, but establishing them has traditionally required equipment from multiple vendors and can take several months of debugging to ensure interoperability. VIAVI and Calnex's offerings are highly complementary, and we've undertaken the complex integration work to create these first-of-their-kind comprehensive testing systems and eliminate the issues that have plagued many developers. Early customer feedback has been positive and we look forward to maximising the partnership's potential across key regions."

Ian Langley, Senior Vice President and General Manager, Wireless Business Unit of VIAVI, said: "During the development phase, many O-RUs are only tested with a single O-DU/O-CU vendor, which results in failure under real-world network conditions. This issue is compounded as the industry lacks tools to emulate realistic fronthaul conditions. Our partnership with Calnex puts these tools directly into the developers' hands to vastly speed up and simplify Open RAN test lab setup."

For more information, please contact:

Calnex Solutions plc

Via Alma

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

Alma Strategic Communications

+ 44(0) 20 3405 0213

Caroline Forde, Joe Pederzolli, Emma Thompson

 

Overview of Calnex

Calnex (LON:CLX) designs, produces and markets test and measurement instrumentation and solutions to enable the validation of the performance of critical infrastructure for the telecoms and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enabling its customers to validate the performance of the critical infrastructure associated with telecoms and cloud computing networks and the applications that run on it. Learn more about Calnex at www.calnexsol.com

 

About VIAVI

VIAVI (NASDAQ: VIAV) is a global provider of network test, monitoring and assurance solutions for telecommunications, cloud, enterprises, first responders, military, aerospace and railway. VIAVI is also a leader in light management technologies for 3D sensing, anti-counterfeiting, consumer electronics, industrial, automotive, government and aerospace applications. Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI Perspectives, LinkedIn and YouTube.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGAPGUPAGQA
Date   Source Headline
10th Jun 20264:17 pmRNSLong-Term Incentive Plan Awards
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.